Volume 30, Issue 3 (December 2023)
J Birjand Univ Med Sci. 2023, 30(3): 231-242 |
Back to browse issues page
Research code: 4321
Ethics code: IR.BUMS.REC.1395.214
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
AmirabadiZadeh A, Khosravi M, Foadoddini M. Reduction of cardiac ischemia-reperfusion injury by curcumin in high-fat diet-fed rats. Journals of Birjand University of Medical Sciences 2023; 30 (3) :231-242
URL: http://journal.bums.ac.ir/article-1-3343-en.html
URL: http://journal.bums.ac.ir/article-1-3343-en.html
1- Farhangian University, Department of Biology, Tehran, Iran
2- Farhangian University, Department of Math& Statistics, Birjand, Iran
3- Cardiovascular Diseases Research Center, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran ,foadmohsen@yahoo.com
2- Farhangian University, Department of Math& Statistics, Birjand, Iran
3- Cardiovascular Diseases Research Center, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran ,
Abstract: (591 Views)
Background and Aims: Curcumin has potential anti-inflammatory effects. The aim of this study was to investigate the protective effect of curcumin against cardiac ischemia -reperfusion injury in rats fed a high-fat diet.
Materials and Methods: In this experimental study, male Wistar rats were divided into four groups: control (C), high-fat diet (H), curcumin 100 (HyperC100, 100 mg/kg) and curcumin 200 (HyperC200), with the last two groups receiving oral curcumin daily for 3 weeks.
The rats were fed a high-fat diet for 7 weeks to induce obesity. After anesthesia, hearts were removed and placed on the Langendorff perfusion system andbegan beating. After 20 minutes of stabilization, 35 minutes of ischemia and 60 minutes of nutrient fluid reflux were performed. During this interval, ventricular (LV) functional indices including LVSP, LVDP, LVEDP and +dp/dt were recorded. The relative size of the infarction was measured by using 2,3,5-triphenyltetrazolium chloride staining.
Results: Hyperlipidemia caused dysfunction with changes in ventricular parameters, but curcumin could to improve some LV contractile parameters such as systolic pressure and increase diastolic pressure (P≤0.05). Curcumin could not significantly reduce the infarct size.
Conclusion: Curcumin may have an cardio protection effects against ischemia/reperfusion injury in normal and hyperlipidemic rats.
*Corresponding Author: Mohsen Foadoddini; Emails: foadmohsen@yahoo.com
Materials and Methods: In this experimental study, male Wistar rats were divided into four groups: control (C), high-fat diet (H), curcumin 100 (HyperC100, 100 mg/kg) and curcumin 200 (HyperC200), with the last two groups receiving oral curcumin daily for 3 weeks.
The rats were fed a high-fat diet for 7 weeks to induce obesity. After anesthesia, hearts were removed and placed on the Langendorff perfusion system andbegan beating. After 20 minutes of stabilization, 35 minutes of ischemia and 60 minutes of nutrient fluid reflux were performed. During this interval, ventricular (LV) functional indices including LVSP, LVDP, LVEDP and +dp/dt were recorded. The relative size of the infarction was measured by using 2,3,5-triphenyltetrazolium chloride staining.
Results: Hyperlipidemia caused dysfunction with changes in ventricular parameters, but curcumin could to improve some LV contractile parameters such as systolic pressure and increase diastolic pressure (P≤0.05). Curcumin could not significantly reduce the infarct size.
Conclusion: Curcumin may have an cardio protection effects against ischemia/reperfusion injury in normal and hyperlipidemic rats.
*Corresponding Author: Mohsen Foadoddini; Emails: foadmohsen@yahoo.com
You can also search for this author in: PubMed ResearchGate Scopus Google Scholar Google Scholar Profile
Type of Study: Original Article |
Subject:
Cardiology
Received: 2023/10/25 | Accepted: 2023/12/23 | ePublished: 2023/12/24
Received: 2023/10/25 | Accepted: 2023/12/23 | ePublished: 2023/12/24
References
1. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023; 147(8): e93-e621. DOI: 10.1161/CIR.0000000000001123 [DOI:10.1161/CIR.0000000000001123] [PMID]
2. Warnholtz A, Mollnau H, Oelze M, Wendt M, Munzel T. Antioxidants and endothelial dysfunction in hyperlipidemia. Curr Hypertens Rep. 2001; 3(1): 53-60. DOI: 10.1007/s11906-001-0081-z [DOI:10.1007/s11906-001-0081-z] [PMID]
3. Csont T, Balogh G, Csonka C, Boros I, Horvath I, Vigh L, et al. Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun. 2002; 290(5): 1535-8. DOI: 10.1006/bbrc.2002.6377 [DOI:10.1006/bbrc.2002.6377] [PMID]
4. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008; 88(2): 581-609. DOI: 10.1152/physrev.00024.2007 [DOI:10.1152/physrev.00024.2007] [PMID] []
5. Kim YS, Kwon JS, Cho YK, Jeong MH, Cho JG, Park JC, et al. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes. J Nutr Biochem. 2012; 23(11): 1514-23. DOI: 10.1016/j.jnutbio.2011.10.004 [DOI:10.1016/j.jnutbio.2011.10.004] [PMID]
6. Jiang S, Han J, Li T, Xin Z, Ma Z, Di W, et al. Curcumin as a potential protective compound against cardiac diseases. Pharmacol Res. 2017; 119: 373-83. DOI: 10.1016/j.phrs.2017.03.001 [DOI:10.1016/j.phrs.2017.03.001] [PMID]
7. Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 2009; 14(1): 22-7. DOI: 10.1177/1074248408329608 [DOI:10.1177/1074248408329608] [PMID]
8. Fiorillo C, Becatti M, Pensalfini A, Cecchi C, Lanzilao L, Donzelli G, et al. Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kappaB, and JNK pathways. Free Radic Biol Med. 2008; 45(6): 839-46. DOI: 10.1016/j.freeradbiomed.2008.06.013 [DOI:10.1016/j.freeradbiomed.2008.06.013] [PMID]
9. Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Sripradha R, Badhe B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm Biol. 2016; 54(12): 2857-63. DOI: 10.1080/13880209.2016.1187179 [DOI:10.1080/13880209.2016.1187179] [PMID]
10. Tu Y, Sun D, Zeng X, Yao N, Huang X, Huang D, et al. Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet. Exp Ther Med. 2014; 8(1): 260-6. DOI: 10.3892/etm.2014.1717 [DOI:10.3892/etm.2014.1717] [PMID] []
11. Amirabadizadeh A, Foaddodini M, Khatamsaz S, Mokhtari M, Shariati M, Hosseini M, et al. Introduction and Optimization of a Dietary Model for Inducing Hyperlipidemia in Rats.J Babol Univ Med Sci. 2017; 19(7): 35-41. [Persian] DOI: 10.22088/jbums.19.7.5
12. Qin Y, Shi Y, Yu Q, Yang S, Wang Y, Dai X, et al. Vitamin B12 alleviates myocardial ischemia/reperfusion injury via the SIRT3/AMPK signaling pathway. Biomed Pharmacother. 2023; 163: 114761. DOI: 10.1016/j.biopha.2023.114761 [DOI:10.1016/j.biopha.2023.114761] [PMID]
13. Tahep ld P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci. 2001; 68(14): 1629-40. DOI: 10.1016/s0024-3205(01)00964-x [DOI:10.1016/S0024-3205(01)00964-X] [PMID]
14. Li T, Jin J, Pu F, Bai Y, Chen Y, Li Y, et al. Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies. Front Pharmacol. 2023; 14: 1111459. DOI: 10.3389/fphar.2023.1111459 [DOI:10.3389/fphar.2023.1111459] [PMID] []
15. Morrison A, Li J. PPAR-gamma and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol. 2011; 82(3): 195-200. DOI: 10.1016/j.bcp.2011.04.004 [DOI:10.1016/j.bcp.2011.04.004] [PMID]
16. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013; 15(1): 195-218. DOI: 10.1208/s12248-012-9432-8 [DOI:10.1208/s12248-012-9432-8] [PMID] []
17. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest. 2008; 118(3): 868-78. DOI: 10.1172/JCI33160 [DOI:10.1172/JCI33160] [PMID] []
18. Wang NP, Wang ZF, Tootle S, Philip T, Zhao ZQ. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. Br J Pharmacol. 2012; 167(7): 1550-62. DOI: 10.1111/j.1476-5381.2012.02109.x [DOI:10.1111/j.1476-5381.2012.02109.x] [PMID] []
19. Zeng YF, Guo QH, Wei XY, Chen SY, Deng S, Liu JJ, et al. Cardioprotective effect of curcumin on myocardial ischemia/reperfusion injury: a meta-analysis of preclinical animal studies. Front Pharmacol. 2023; 14: 1184292. DOI: 10.3389/fphar.2023.1184292 [DOI:10.3389/fphar.2023.1184292] [PMID] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC